Roche

News

Roche's Hemlibra approved in expanded haemophilia A use

Roche’s Hemlibra has been approved in an expanded use in haemophilia A in the US, as the Swiss firm seeks to build a new blockbuster franchise in rare diseases.

News

Trial shows Roche's new flu drug helps reduce symptoms in at...

Baloxavir marboxil, a flu drug seen by Roche as a successor to Tamiflu, significantly sped time to relief for patients highly vulnerable to serious complications.

News

Roche aims to extend shelf life of Xolair with new prefilled...

The FDA has approved a new prefilled syringe formulation for Roche’s asthma drug Xolair, as the Swiss company aims to prolong its shelf life.

News

Roche buys Tusk, plus cancer immunotherapy drug, for £62m

Roche has bought immuno-oncology biotech firm Tusk Therapeutics for an upfront payment of £62 million.

News

Roche Ieso digital health therapeutics mental health

Roche Diabetes Care partners with digital therapeutics firm ...

Roche’s diabetes arm is working with Ieso Digital Health to test the Cambridge, UK-based digital therapeutics firm’s mental health programme in type 2 diabetes patients in the UK and Irelan

News

Latest lung cancer data could open new avenue for Roche's Te...

Roche is eyeing a new use for its checkpoint inhibitor immunotherapy Tecentriq after it posted results showing it extended patients’ lives by an extra two months compared with chemotherapy

Roche's Hemlibra approved in expanded haemophilia A use

Trial shows Roche's new flu drug helps reduce symptoms in at...

Roche aims to extend shelf life of Xolair with new prefilled...

Roche buys Tusk, plus cancer immunotherapy drug, for £62m

Roche Diabetes Care partners with digital therapeutics firm ...

Latest lung cancer data could open new avenue for Roche's Te...

UK offers meningitis jab to young people after outbreak

Discover a new era of healthcare panel engagement: Grounded ...

Roche

Editor's Picks